Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Dengue viruses (DENVs) infect approximately 400 million people each year, and currently, there are no effective therapeutics available. To explore potential starting points for antiviral drug development, we conducted a large-scale crystallographic fragment screen targeting the RNA-dependent RNA polymerase (RdRp) domain of the nonstructural protein 5 (NS5) from DENV serotype 2. Our screening, which involved 1108 fragments, identified 60 hit compounds across various known binding sites, including the active site, N pocket, and RNA tunnel. Additionally, we discovered a novel binding site and a fragment-binding hot spot in thumb site II. These structural findings open amenable avenues for developing non-nucleoside inhibitors and offer valuable insights for future structure-based drug design aimed at DENV and other flaviviral RdRps.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jmedchem.5c01014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A New Fragment-Based Pharmacophore Virtual Screening Workflow Identifies Potent Inhibitors of SARS-CoV-2 NSP13 Helicase.
J Comput Chem
September 2025
Johnson & Johnson, Beerse, Belgium.
Herein we report the in silico discovery of 13 novel micromolar potent inhibitors of the SARS-CoV-2 NSP13 helicase validated in cellular antiviral and biophysical ThermoFluor assays. The compounds, discovered using a novel fragment-based pharmacophore virtual screening workflow named FragmentScout, enable the advancement of novel antiviral agents. FragmentScout uses publicly accessible structural data of the SARS-CoV-2 NSP13 helicase, which was previously generated at the Diamond LightSource by XChem high-throughput crystallographic fragment screening.
View Article and Find Full Text PDFCrystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals.
J Med Chem
September 2025
Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.
Dengue viruses (DENVs) infect approximately 400 million people each year, and currently, there are no effective therapeutics available. To explore potential starting points for antiviral drug development, we conducted a large-scale crystallographic fragment screen targeting the RNA-dependent RNA polymerase (RdRp) domain of the nonstructural protein 5 (NS5) from DENV serotype 2. Our screening, which involved 1108 fragments, identified 60 hit compounds across various known binding sites, including the active site, N pocket, and RNA tunnel.
View Article and Find Full Text PDFResolving the Capacity-Stability-Cost Trilemma in Multi-Principal-Element Hydrogen Storage Alloys Through Multi-Objective Optimization.
Adv Sci (Weinh)
August 2025
School of Advanced Energy, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China.
Overcoming the capacity-stability-cost trilemma in hydrogen storage materials represents a fundamental Pareto-type challenge for practical metal hydride applications. Current research efforts remain fragmented, typically pursuing single-parameter optimization while lacking holistic approaches that concurrently satisfy all three criteria. Here, a novel design paradigm is proposed by orchestrating A/B-side multi-principal-element alloys (MPEAs) in C14 Laves phases, enabling concurrent optimization of interstitial hydrogen storage environments and thermodynamics.
View Article and Find Full Text PDFCrystallographic Snapshots of Pre- and Post-Lanthanide Halide HydrolysisReaction Products Captured by the 4‑Amino-1,2,4-triazole Ligand.
Cryst Growth Des
August 2025
Department of Chemistry, University of Wyoming, 1000 E, University Ave, Laramie, Wyoming 82071, United States.
Reactions of lanthanide-(III) chloride salts with 4-amino-1,2,4-triazole (4-NH-1,2,4-Triaz) in azole melts have led to the isolation of both hydrolysis and nonhydrolysis products in the same synthesis, with the inclusion of a variety of ligands, anions, and water, allowing us to capture crystallographic snapshots of different forms and intermediate hydrolysis fragments. The structural studies reported here include anhydrous and hydrated nonhydrolyzed complexes, which were isolated alongside hydrolysis products, giving oxide/hydroxide lanthanide-(III) dimers, tetramers, and ultimately hexamers. The compounds isolated include [NdCl(μ-4-NH-1,2,4-Triaz)(4-NH-1,2,4-Triaz)], [CeCl(μ-Cl)(μ-4-NH-1,2,4-Triaz)], [Ce(μ-Cl)(μ-OH)(μ-4-NH-1,2,4-Triaz)], [LnCl(μ-Cl)(μ-OH)(μ-4-NH-1,2,4-Triaz)]·2HO (Ln = Ce, Nd), and [CeCl(μ-O)-(μ-Cl)(μ-Cl)(μ-OH)(μ-4-NH-1,2,4-Triaz)((OH))][CeCl]-[Cl]·HO.
View Article and Find Full Text PDFFragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction.
Angew Chem Int Ed Engl
August 2025
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2100, Denmark.
Activating the cytoprotective response of nuclear factor erythroid 2-related factor 2 (Nrf2) can reduce oxidative stress and inflammation. A promising strategy is to inhibit the protein-protein interaction between Kelch-like ECH-associated protein 1 (Keap1) and Nrf2 using noncovalent compounds that target the Keap1 Kelch domain. These compounds may be more specific than covalent Keap1-reacting Nrf2 activators.
View Article and Find Full Text PDF